Literature DB >> 3140760

Restrictive cardiomyopathy with kappa light chain deposits in myocardium as a complication of multiple myeloma. Histochemical and electron microscopic observations.

H A McAllister1, J Seger, M Bossart, V J Ferrans.   

Abstract

kappa Light chain deposits occurring in myocardium as a complication of multiple myeloma were identified ultrastructurally and immunohistochemically in a right ventricular endomyocardial biopsy specimen from a patient who presented with clinical and hemodynamic findings of restrictive cardiomyopathy. These deposits were not evident on routine histopathologic examination; they were Congo red-negative and gave a positive immunoperoxidase reaction for kappa light chains and a negative reaction for lambda chains. They consisted of amorphous, electron-dense granules that formed discontinuous layers adjacent to the plasma membranes of cardiac myocytes, arteriolar endothelial and smooth-muscle cells, and neural elements. These observations underscore the need for critical study of endomyocardial biopsy specimens, using electron microscopy and immunohistochemical reagents, for the precise identification of protein components in tissue deposits in patients suspected of having cardiac amyloidosis or related disorders.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3140760

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  3 in total

Review 1.  Endomyocardial biopsy in the evaluation of conditions leading to cardiac transplantation and in the evaluation of cardiac allograft rejection.

Authors:  H A McAllister
Journal:  Tex Heart Inst J       Date:  1995

2.  Systemic lambda light-chain deposition presenting with predominant cardiac involvement.

Authors:  M J Garton; S Walton; S W Ewen
Journal:  Postgrad Med J       Date:  1993-07       Impact factor: 2.401

3.  Light chain cardiomyopathy. Structural analysis of the light chain tissue deposits.

Authors:  G Gallo; F Goñi; F Boctor; R Vidal; A Kumar; F J Stevens; B Frangione; J Ghiso
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.